In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Christen M CrostaDepartment of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.ORCID 0000-0003-1975-2782 Brandon J VaglioDepartment of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.ORCID 0000-0002-2016-9212 Joshua StuckeyDepartment of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.ORCID 0000-0002-9695-2211 Atul K BhattiproluDepartment of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.ORCID 0000-0003-2939-4309 Johanne SolisBrain Health Institute, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.ORCID 0009-0007-2113-1746 Jared LampIntegrated Mass Spectrometry Unit, Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.ORCID 0000-0002-7187-7657 Andrew UmsteadIntegrated Mass Spectrometry Unit, Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.
Irving E VegaIntegrated Mass Spectrometry Unit, Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA.ORCID 0000-0002-7960-9534 Steven M SilversteinDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0002-0699-0960 Bonnie L FiresteinDepartment of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.ORCID 0000-0002-1679-3565 Funding
Metabolic Mechanisms of Recovery in Mild TBIR01NS135406 · NINDS · UNIVERSITY OF KENTUCKY · PI BONNIE L FIRESTEIN, DAVID F MEANEY · 2024 to 2026
$1.8MNINDS NIH HHS R01 NS135406
6 · The paper itselfAbstract
Schizophrenia (SCZ) is heterogenous and polygenic, making it difficult to diagnose and treat. This is expected as diagnostic criteria are solely based on behavioral markers. There is a critical need for easy-to-collect biomarkers that aid in treatment. To identify potential biomarkers, we recruited patients with SCZ and controls. Using buccal cell lysates, we performed real-time quantitative polymerase chain reaction and identified significant differences in
Indexed as
Chaperonin 60Mouth MucosaSchizophreniaAdultBiomarkersCase-Control StudiesFemaleGene Expression RegulationHumansMaleMiddle AgedRNA, MessengerBiomarkersChaperonin 60RNA, Messenger
Identifiers
PMID41779859
PMCPMC12959401
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390